Study Stopped
Investigator's decision (departure from institution)
Impact of an Early Palliative Approach
MAHO2
Impact of an Early and Collegial Consideration of Patients' Vulnerability Comparing to Usual Care. Cluster Randomized Control Study "Mort-A-l'Hôpital 2"
2 other identifiers
interventional
1,200
1 country
23
Brief Summary
In 2003, MAHO study (Ferrand E, Jabre P, Vincent-Genod C, et al. Circumstances of death in hospitalized patients and nurses' perceptions: French multicenter Mort-a-l'Hôpital survey. Arch Intern Med. 2008 168: 867-875.) evaluated the way 3793 patients died in 200 French hospitals and showed that their conditions of death were not optimal. The 22th April 2005 French Law precised patient's end of life rights with necessity to refrain from any unreasonable obstinacy, the right to refuse treatments and the obligation of a collegial process decision when the patient is not conscious. Since then, studies haven't demonstrate any improvement and found that palliative strategy in France is much less used than in other developed countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
23 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 17, 2016
CompletedFirst Posted
Study publicly available on registry
September 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedMay 17, 2019
May 1, 2019
5.3 years
February 17, 2016
May 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of withdraw/withhold of treatment in each group
To evaluate the impact of an early palliative strategy using vulnerability criteria compared to standard care.
From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital
Secondary Outcomes (4)
Death conditions
From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital
Early vulnerability consideration impact on length of stay
From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital
Palliative strategy modalities
From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital
Early vulnerability consideration impact on caregivers' satisfaction
From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital
Study Arms (2)
Usual Practices
OTHERUsual Practices
Early consideration of vulnerability
OTHERStrategy promoting early consideration of patients' vulnerability
Interventions
One day training with the provision of vulnerability criteria inciting an early reflection of the level of therapeutic engagement; sheets available on the internet computer support collegial reflection and traceability of decisions to limit and stop treatments, incorporating the provisions of law known Leonetti
Eligibility Criteria
You may qualify if:
- Patient more than 18 years old hospitalized for at least 24h and who's prognosis (survival or quality of life) should lead to a palliative approach
- Patient suffering with at least one of the following vulnerability criteria will be included:
- Evolutive and symptomatic incurable cancer
- Aged more than 75 years old and presenting several geriatric syndromes (cognitive disorders, isolation, malnutrition, bedridden more than 12h per day)
- Neurologic pathology, chronic, with loss of autonomy (Performance Status\>3)
- Final organ failure (heart, lungs, liver, kidney) with loss of autonomy (Performance Status\>3)
- Care refusal and/or expressed will to die or repeated request for help to die
You may not qualify if:
- Minors
- Patients without indication for treatment or surveillance with length of stay inferior to 24h
- Brain dead patients
- Not consent patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital Fochlead
Study Sites (23)
CHU
Amiens, 80000, France
Hopital privé Oncologie Médicale
Antony, 92160, France
Hôpital Privé Medecine interne
Antony, 92160, France
Hôpital Avicenne
Bobigny, 93000, France
Hôpital Ambroise Paré
Boulogne-Billancourt, 92100, France
Hôpital Georges Clemenceau
Champcueil, 91750, France
CHU
Dijon, 21000, France
Centre Hospitalier
Épernay, 51200, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
CHRU
Lille, 59000, France
Hopital Lariboisiere Medecine interne
Paris, 75010, France
Groupe Hospitalier Paris - Saint-Joseph
Paris, 75014, France
Hopital Cochin Gastro-Enterologie
Paris, 75014, France
Centre Hospitalier Universitaire
Poitiers, 86000, France
Centre Hospitalier
Roubaix, 59100, France
Centre Hospitalier de Soissons
Soissons, 02200, France
Hiopital Foch Néphrologie
Suresnes, 92150, France
Hopital Foch Cardiologie
Suresnes, 92150, France
Hopital Foch Chirurgie Urologique
Suresnes, 92150, France
Hopital Foch Médecine Interne
Suresnes, 92150, France
Hopital Foch Neurochirurgie
Suresnes, 92150, France
Hopîtal Foch Urgences
Suresnes, 92150, France
CH
Valenciennes, 59300, France
Related Publications (12)
Truog RD, Cist AF, Brackett SE, Burns JP, Curley MA, Danis M, DeVita MA, Rosenbaum SH, Rothenberg DM, Sprung CL, Webb SA, Wlody GS, Hurford WE. Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med. 2001 Dec;29(12):2332-48. doi: 10.1097/00003246-200112000-00017. No abstract available.
PMID: 11801837BACKGROUNDFerrand E, Jabre P, Vincent-Genod C, Aubry R, Badet M, Badia P, Cariou A, Ellien F, Gounant V, Gil R, Jaber S, Jay S, Paillaud E, Poulain P, Regnier B, Reignier J, Socie G, Tardy B, Lemaire F, Brun-Buisson C, Marty J; French Mort-a-l'Hopital Group. Circumstances of death in hospitalized patients and nurses' perceptions: French multicenter Mort-a-l'Hopital survey. Arch Intern Med. 2008 Apr 28;168(8):867-75. doi: 10.1001/archinte.168.8.867.
PMID: 18443263RESULTFerrand E, Robert R, Ingrand P, Lemaire F; French LATAREA Group. Withholding and withdrawal of life support in intensive-care units in France: a prospective survey. French LATAREA Group. Lancet. 2001 Jan 6;357(9249):9-14. doi: 10.1016/s0140-6736(00)03564-9.
PMID: 11197395RESULTFerrand E, Lemaire F, Regnier B, Kuteifan K, Badet M, Asfar P, Jaber S, Chagnon JL, Renault A, Robert R, Pochard F, Herve C, Brun-Buisson C, Duvaldestin P; French RESSENTI Group. Discrepancies between perceptions by physicians and nursing staff of intensive care unit end-of-life decisions. Am J Respir Crit Care Med. 2003 May 15;167(10):1310-5. doi: 10.1164/rccm.200207-752OC. Epub 2003 Jan 24.
PMID: 12738597RESULTFerrand E, Marty J; French LATASAMU Group. Prehospital withholding and withdrawal of life-sustaining treatments. The French LATASAMU survey. Intensive Care Med. 2006 Oct;32(10):1498-505. doi: 10.1007/s00134-006-0292-5. Epub 2006 Aug 2.
PMID: 16896861RESULTPrendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998 Oct;158(4):1163-7. doi: 10.1164/ajrccm.158.4.9801108.
PMID: 9769276RESULTSprung CL, Cohen SL, Sjokvist P, Baras M, Bulow HH, Hovilehto S, Ledoux D, Lippert A, Maia P, Phelan D, Schobersberger W, Wennberg E, Woodcock T; Ethicus Study Group. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003 Aug 13;290(6):790-7. doi: 10.1001/jama.290.6.790.
PMID: 12915432RESULTFerrand E, Jabre P, Fernandez-Curiel S, Morin F, Vincent-Genod C, Duvaldestin P, Lemaire F, Herve C, Marty J. Participation of French general practitioners in end-of-life decisions for their hospitalised patients. J Med Ethics. 2006 Dec;32(12):683-7. doi: 10.1136/jme.2005.014084.
PMID: 17145904RESULTTemel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
PMID: 20818875RESULTKelley AS, Meier DE. Palliative care--a shifting paradigm. N Engl J Med. 2010 Aug 19;363(8):781-2. doi: 10.1056/NEJMe1004139. No abstract available.
PMID: 20818881RESULTGreer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, Gallagher ER, Temel JS. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012 Feb 1;30(4):394-400. doi: 10.1200/JCO.2011.35.7996. Epub 2011 Dec 27.
PMID: 22203758RESULTYoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013 Feb 25;173(4):283-90. doi: 10.1001/jamainternmed.2013.1874.
PMID: 23358690RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Edouard Ferrand, MD
e.ferrand@hopital-foch.org
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2016
First Posted
September 20, 2016
Study Start
November 1, 2013
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
May 17, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share